New and updated preclinical and clinical data to be presented by biopharma firms at the American Society of Clinical Oncology’s annual meeting May 29-31, including: Allogene, Arvinas, Astrazeneca, Exelixis, Eli Lilly, Galera, Heat, Helsinn, Immunogen, Innate, Innovent, Inovio, Janssen, Kyowa, Legend, Marker, MEI, Merck, Targovax, Tarveda, Tiziana, Vaximm, Xencor.